Neurocrine Biosciences Inc. said Joseph Mollica plans to retire as a director of the company, effective Oct. 17.
Neurocrine Biosciences director to retire
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help